Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.

Kraft-Terry SD, Buch SJ, Fox HS, Gendelman HE.

Neuron. 2009 Oct 15;64(1):133-45. doi: 10.1016/j.neuron.2009.09.042. Review.

2.

Dopaminergic neurotoxicity of HIV-1 gp120: reactive oxygen species as signaling intermediates.

Agrawal L, Louboutin JP, Marusich E, Reyes BA, Van Bockstaele EJ, Strayer DS.

Brain Res. 2010 Jan 8;1306:116-30. doi: 10.1016/j.brainres.2009.09.113. Epub 2009 Oct 6.

PMID:
19815008
3.

CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.

Yadav A, Collman RG.

J Neuroimmune Pharmacol. 2009 Dec;4(4):430-47. doi: 10.1007/s11481-009-9174-2. Epub 2009 Sep 19. Review.

PMID:
19768553
4.

HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.

Coleman CM, Wu L.

Retrovirology. 2009 Jun 1;6:51. doi: 10.1186/1742-4690-6-51. Review.

5.

Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Woods SP, Moore DJ, Weber E, Grant I.

Neuropsychol Rev. 2009 Jun;19(2):152-68. doi: 10.1007/s11065-009-9102-5. Epub 2009 May 22. Review.

6.

Monocyte chemoattractant protein-1 (MCP-1): an overview.

Deshmane SL, Kremlev S, Amini S, Sawaya BE.

J Interferon Cytokine Res. 2009 Jun;29(6):313-26. doi: 10.1089/jir.2008.0027. Review.

7.

HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: protection by rSV40 delivery of antioxidant enzymes.

Louboutin JP, Agrawal L, Reyes BA, Van Bockstaele EJ, Strayer DS.

Neurobiol Dis. 2009 Jun;34(3):462-76. doi: 10.1016/j.nbd.2009.03.003. Epub 2009 Mar 25.

PMID:
19327399
8.

Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment.

Toro-Nieves DM, Rodriguez Y, Plaud M, Ciborowski P, Duan F, Pérez Laspiur J, Wojna V, Meléndez LM.

J Neurovirol. 2009 Jan;15(1):36-50. doi: 10.1080/13550280802385505. Epub 2008 Dec 26.

9.

Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment.

Velázquez I, Plaud M, Wojna V, Skolasky R, Laspiur JP, Meléndez LM.

J Neuroimmunol. 2009 Jan 3;206(1-2):106-11. doi: 10.1016/j.jneuroim.2008.10.013. Epub 2008 Dec 19.

10.

Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk.

Wang T, Gong N, Liu J, Kadiu I, Kraft-Terry SD, Mosley RL, Volsky DJ, Ciborowski P, Gendelman HE.

PLoS One. 2008 Jun 25;3(6):e2507. doi: 10.1371/journal.pone.0002507.

11.

Roles of MCP-1 in development of HIV-dementia.

Dhillon NK, Williams R, Callen S, Zien C, Narayan O, Buch S.

Front Biosci. 2008 May 1;13:3913-8.

12.

CSF proteomic fingerprints for HIV-associated cognitive impairment.

Laspiur JP, Anderson ER, Ciborowski P, Wojna V, Rozek W, Duan F, Mayo R, Rodríguez E, Plaud-Valentín M, Rodríguez-Orengo J, Gendelman HE, Meléndez LM.

J Neuroimmunol. 2007 Dec;192(1-2):157-70. Epub 2007 Oct 22. Erratum in: J Neuroimmunol. 2008 Dec 15;205(1-2):161.

13.

Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment.

Rozek W, Ricardo-Dukelow M, Holloway S, Gendelman HE, Wojna V, Melendez LM, Ciborowski P.

J Proteome Res. 2007 Nov;6(11):4189-99. Epub 2007 Oct 12.

PMID:
17929958
14.

Updated research nosology for HIV-associated neurocognitive disorders.

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE.

Neurology. 2007 Oct 30;69(18):1789-99. Epub 2007 Oct 3.

15.

Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome.

Ciborowski P, Kadiu I, Rozek W, Smith L, Bernhardt K, Fladseth M, Ricardo-Dukelow M, Gendelman HE.

Virology. 2007 Jun 20;363(1):198-209. Epub 2007 Feb 22.

16.

Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment.

Wojna V, Skolasky RL, Hechavarría R, Mayo R, Selnes O, McArthur JC, Meléndez LM, Maldonado E, Zorrilla CD, García H, Kraiselburd E, Nath A.

J Neurovirol. 2006 Oct;12(5):356-64.

PMID:
17065128
17.

Statistical analysis of the experimental variation in the proteomic characterization of human plasma by two-dimensional difference gel electrophoresis.

Corzett TH, Fodor IK, Choi MW, Walsworth VL, Chromy BA, Turteltaub KW, McCutchen-Maloney SL.

J Proteome Res. 2006 Oct;5(10):2611-9.

PMID:
17022632
18.

Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.

Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW Jr, Sowder RC 2nd, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE.

J Virol. 2006 Sep;80(18):9039-52.

19.

Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases.

Kadiu I, Glanzer JG, Kipnis J, Gendelman HE, Thomas MP.

Neurotox Res. 2005 Oct;8(1-2):25-50. Review.

PMID:
16260384
20.

Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia.

Deshpande M, Zheng J, Borgmann K, Persidsky R, Wu L, Schellpeper C, Ghorpade A.

Neurotox Res. 2005;7(3):183-92.

PMID:
15897153

Supplemental Content

Support Center